Bipartisan battle over prescription intermediaries heats up
The intermediaries in the prescription drug supply chain are stuck between a rock and a hard place, facing congressional scrutiny and pharmaceutical-industry-backed efforts to reform the multibillion-dollar industry. Pharmacy benefit managers (PBMs) have emerged as a bipartisan target in a divided Congress. Members across the aisle have introduced at least a dozen bills so far…